Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04167137
Title Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Subjects
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Synlogic
Indications

lymphoma

Advanced Solid Tumor

Therapies

SYNB1891

Atezolizumab + SYNB1891

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.